Colgate-Palmolive Company $CL Stock Holdings Lessened by Villere ST Denis J & Co. LLC

Posted by Geri Gentry on Nov 10th, 2026

Villere ST Denis J & Co. LLC lessened its stake in Colgate-Palmolive Company (NYSE:CL – Free Report) by 6.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 180,255 shares of the company’s stock after selling 12,967 shares during the quarter. Colgate-Palmolive makes up 1.6% of Villere ST Denis J & Co. LLC’s holdings, making the stock its 27th biggest position. Villere ST Denis J & Co. LLC’s holdings in Colgate-Palmolive were worth $15,379,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in CL. Virginia Estate & Retirement Planning Advisors Inc. increased its holdings in Colgate-Palmolive by 1,409.1% during the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company’s stock worth $28,000 after buying an additional 310 shares during the last quarter. Parvin Asset Management LLC acquired a new stake in Colgate-Palmolive in the second quarter valued at $32,000. Park Place Capital Corp lifted its stake in Colgate-Palmolive by 55.5% in the second quarter. Park Place Capital Corp now owns 356 shares of the company’s stock valued at $33,000 after acquiring an additional 127 shares during the last quarter. Cherry Tree Wealth Management LLC grew its position in shares of Colgate-Palmolive by 7,840.0% in the 2nd quarter. Cherry Tree Wealth Management LLC now owns 397 shares of the company’s stock valued at $36,000 after acquiring an additional 392 shares during the period. Finally, Montgomery Financial Services LLC bought a new position in shares of Colgate-Palmolive in the 2nd quarter valued at about $36,000. 80.41% of the stock is owned by institutional investors.

Insider Activity

In related news, COO Panagiotis Tsourapas sold 19,938 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $98.74, for a total transaction of $1,968,678.12. Following the completion of the sale, the chief operating officer directly owned 9,111 shares of the company’s stock, valued at approximately $899,620.14. This trade represents a 68.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider John Hazlin sold 23,376 shares of the business’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $99.15, for a total value of $2,317,730.40. Following the completion of the sale, the insider owned 27,021 shares of the company’s stock, valued at $2,679,132.15. This trade represents a 46.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 73,314 shares of company stock valued at $7,212,109. 0.43% of the stock is owned by insiders.

Colgate-Palmolive Stock Performance

NYSE CL opened at $97.90 on Tuesday. The stock has a market cap of $77.82 billion, a PE ratio of 38.39, a P/E/G ratio of 4.48 and a beta of 0.31. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.30 and a current ratio of 0.96. The firm has a 50-day moving average of $90.26 and a 200-day moving average of $90.04. Colgate-Palmolive Company has a 52-week low of $75.96 and a 52-week high of $101.18.

Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, October 30th. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. The business had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.34 billion. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. Colgate-Palmolive’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 EPS. On average, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.92 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s payout ratio is currently 83.14%.

Analysts Set New Price Targets

CL has been the topic of a number of research analyst reports. Barclays upped their target price on shares of Colgate-Palmolive from $87.00 to $95.00 and gave the company an “equal weight” rating in a report on Tuesday, November 3rd. Bank of America lifted their price target on Colgate-Palmolive from $100.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, November 2nd. Piper Sandler reduced their price target on Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating for the company in a report on Monday, September 21st. Weiss Ratings downgraded Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 2nd. Finally, Raymond James Financial upped their price objective on Colgate-Palmolive from $100.00 to $102.00 and gave the company an “outperform” rating in a research note on Monday, August 3rd. Thirteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.22.

Read Our Latest Stock Analysis on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food.

The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world.

Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.